Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $86,379 - $109,312
322 Added 43.99%
1,054 $287,000
Q1 2024

May 10, 2024

SELL
$304.11 - $351.99 $195,846 - $226,681
-644 Reduced 46.8%
732 $253,000
Q4 2023

Jan 30, 2024

BUY
$269.37 - $365.04 $119,600 - $162,077
444 Added 47.64%
1,376 $444,000
Q3 2023

Oct 25, 2023

SELL
$350.25 - $422.63 $433,609 - $523,215
-1,238 Reduced 57.05%
932 $334,000
Q2 2023

Aug 03, 2023

BUY
$359.49 - $486.4 $122,945 - $166,348
342 Added 18.71%
2,170 $822,000
Q1 2023

Apr 24, 2023

SELL
$418.69 - $503.0 $276,754 - $332,483
-661 Reduced 26.56%
1,828 $875,000
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $507,517 - $658,022
-1,443 Reduced 36.7%
2,489 $1.05 Million
Q3 2022

Oct 07, 2022

BUY
$412.59 - $563.26 $827,242 - $1.13 Million
2,005 Added 104.05%
3,932 $1.64 Million
Q2 2022

Aug 10, 2022

SELL
$463.67 - $597.16 $1.65 Million - $2.13 Million
-3,569 Reduced 64.94%
1,927 $954,000
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $75,538 - $105,900
144 Added 2.69%
5,496 $3.1 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $117,667 - $131,916
166 Added 3.2%
5,352 $4.04 Million
Q3 2021

Nov 08, 2021

BUY
$657.71 - $825.77 $2.36 Million - $2.96 Million
3,585 Added 223.92%
5,186 $3.87 Million
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $258,911 - $291,418
449 Added 38.98%
1,601 $1.03 Million
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $1.05 Million - $1.27 Million
-1,913 Reduced 62.41%
1,152 $658,000
Q4 2020

Feb 10, 2021

SELL
$510.68 - $643.45 $520,893 - $656,319
-1,020 Reduced 24.97%
3,065 $1.79 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $155,869 - $183,710
343 Added 9.17%
4,085 $2.11 Million
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $453,079 - $667,110
1,353 Added 56.63%
3,742 $1.69 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $764,503 - $977,268
2,389 New
2,389 $837,000
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $197,273 - $230,881
-617 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $187,907 - $213,013
617 New
617 $205,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.46B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.